- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Curacle Co Ltd (365270)
Curacle Co Ltd stock price live, this page displays KQ 365270 stock exchange data. View the 365270 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Curacle Co Ltd real time stock price chart below.
What Is the Curacle Co Ltd Stock Price Today?
The Curacle Co Ltd stock price today is 18,430.
What Is the Stock Symbol for Curacle Co Ltd?
The stock symbol for Curacle Co Ltd is "365270."
What Stock Exchange Does Curacle Co Ltd Trade On?
Curacle Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Curacle Co Ltd a Good Stock to Buy?
Determining whether Curacle Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 365270 quote. (ISIN: KR7365270008)
What Is the Curacle Co Ltd Stock Price Today?
The Curacle Co Ltd stock price today is 18,430.
What Is the Stock Symbol for Curacle Co Ltd?
The stock symbol for Curacle Co Ltd is "365270."
What Stock Exchange Does Curacle Co Ltd Trade On?
Curacle Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Curacle Co Ltd a Good Stock to Buy?
Determining whether Curacle Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 365270 quote. (ISIN: KR7365270008)
KOSDAQ
Currency in KRW
18,430
+620(+3.48%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17,650
18,700
52 wk Range
3,600
20,750
365270 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17,65018,700
52 wk Range
3,60020,750
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
365270 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Biotechnology industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
curacle co.,ltd., a bio-venture business, engages in the research and development of drugs for intractable vascular and metabolic diseases due to aging. The company’s products in pipeline include CU06, a next-generation oral therapy, which completed phase 2a clinical trial for the treatment of diabetic macular edema; CU01, which completed Phase 2b clinical trial for Nrf2 activation and inhibition of TGF- ß/Smad signaling; MT-101, a fully humanized Tie2 agonist antibody for the treatment of renal diseases; and MT-103, a bispecific antibody combining Tie2 agonist and anti-VEGF functions for the treatment of wAMD. It also develops MT-105 for the treatment of irritable bowel diseases; MT-201, a non-bleeding anti-thrombotic antibody targeting PD-X; MT-202, a dual-mechanism therapy combining PD-X inhibition and Tie2 agonism for the treatment of acute ischemic stroke and heart failure with preserved ejection fraction; CU71, a next-generation neurovascular stabilizer for the treatment of alzheimer's disease; and CP01-R01, a first oral endothelial stabilizer–based candidate for companion animal CKD therapy. In addition, the company develops SOLVADYS, proprietary oral small-molecule platform for the treatment of endothelial dysfunction; and EAGLES, a flagship platform of Maptics for next-generation biologics. curacle co.,ltd. was incorporated in 2016 and is headquartered in Seoul, South Korea.
Compare 365270 to Peers and Sector
Metrics to compare | 365270 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship365270PeersSector | |
|---|---|---|---|---|
P/E Ratio | −22.4x | −8.3x | −0.5x | |
PEG Ratio | 9.84 | −0.13 | 0.00 | |
Price/Book | 10.1x | 3.6x | 2.6x | |
Price / LTM Sales | 344.5x | 13.1x | 3.1x | |
Upside (Analyst Target) | - | 0.0% | 57.6% | |
Fair Value Upside | Unlock | 8.2% | 8.6% | Unlock |
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
-191.00 / --
Revenue / Forecast
7.1M / --
People Also Watch
FAQ
What Is the Curacle Co (365270) Stock Price Today?
The Curacle Co stock price today is 18,430 KRW.
What Stock Exchange Does Curacle Co Trade On?
Curacle Co is listed and trades on the KOSDAQ.
What Is the Stock Symbol for Curacle Co?
The stock symbol for Curacle Co is "365270."
What Is the Curacle Co Market Cap?
As of today, Curacle Co market cap is 392.63B KRW.
What Is Curacle Co's Earnings Per Share (TTM)?
The Curacle Co EPS (TTM) is -1,217.
From a Technical Analysis Perspective, Is 365270 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Curacle Co Stock Split?
Curacle Co has split 0 times.
What is the current trading status of Curacle Co (365270)?
As of Mar 21, 2026, Curacle Co (365270) is trading at a price of 18,430 KRW, with a previous close of 17,810 KRW. The stock has fluctuated within a day range of 17,650 KRW to 18,700 KRW, while its 52-week range spans from 3,600 KRW to 20,750 KRW.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.